Product & Industry News
Page 1 to 16 of 64 |     NEXT PAGE >
PerkinElmer Launches chemagic Prime Instrument for Automated Nucleic Acid Isolation and Assay Set-Up
Leverages Advanced Magnetic Bead-Based Technology to Support Next Gen Sequencing, Genotyping, PCR and MLPA in Human Samples

Read More

Plasticell and GSK sign collaboration agreement to produce hematopoietic cells from iPSCs
Plasticell, has entered into a collaboration with GSK to use its combinatorial stem cell screening technology, CombiCult, to optimise the directed differentiation of induced pluripotent stem cells (iPSCs) to specific blood cell lineages for use by GSK in its therapeutic research.

Read More

TTP Plc and Sphere Fluidics introduce Cyto-Mine Single Cell Analysis System
TTP Plc, and Sphere Fluidics have announced the launch of the Cyto-Mine Single Cell Analysis System. The Cyto-Mine system automates single cell analysis, sorting, imaging and dispensing to help boost throughput and sensitivity throughout the biopharmaceutical discovery process.

Read More

Desktop Genetics introduces new series of customizable CRISPR libraries
Desktop Genetics Ltd, a company revolutionizing the way biologists use CRISPR genome editing technology, has today announced the launch of its DESKGEN Series CRISPR Libraries to support gene editing efforts in academic and biopharma settings.

Read More

Irvine Scientific Introduces Arctic Sperm Cryopreservation Medium
Irvine Scientific, a world leader in the development and manufacture of cell culture media and Assisted Reproductive Technologies (ART), today announced the introduction of Arctic Sperm Cryopreservation Medium.

Read More

Gyros Protein Technologies signs distribution agreement with Euro Diagnostica
Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today announced it has signed a distribution agreement with Euro Diagnostica, the full service assay solution company.

Read More

Optibrium Joins EUR 40 Million eTRANSAFE project
Optibrium, a developer of software for small molecule drug discovery, has announced that it will join the Enhancing Translational Safety Assessment through Integrative Knowledge Management (eTRANSAFE) project.

Read More

Avacta initiates gene therapy research collaboration with FIT Biotech Oy
Avacta Group is pleased to announce it has initiated a research collaboration with FIT Biotech Oy to assess the effectiveness of developing gene therapies using Avacta’s Affimer technology combined with FIT Biotech’s gtGTU platform.

Read More

Desktop Genetics opens £1.5 million investment round via SyndicateRoom
Desktop Genetics Ltd (DTG), a software company revolutionising the way biologists use CRISPR genome editing technology, and online investment platform SyndicateRoom today announce the opening of a £1.5 million investment round. DTG plans to use the funds to commercialise products and support its expansion into the US.

Read More

Analytik Jena's qTOWER Product Family Sets New Standards for qPCR
Analytik Jena's qTOWER product family guarantees well-founded results for all real-time PCR applications as it benefits from peerless temperature control precision in the sample block regardless of the number of samples used – ranging from 96 up to 384 samples.

Read More

New Patent Issued to BioTek for Laser Autofocus Method
BioTek Instruments has announced that the United States Patent and Trademark Office has issued a patent to the Company for its "Autofocus for Imaging System" invention used in the Cytation and Lionheart FX products.

Read More

World's first physiologically relevant, in vitro Ischemia-Reperfusion Model
Luxcel Biosciences Ltd announce world's first physiologically relevant, in vitro Ischemia-Reperfusion Model in conjunction with BMG LABTECH and Ncardia.

Read More

Irvine Scientific Increases Production Capacity of Dry Powder Media for Cell Culture
Irvine Scientific, a world leader in cell culture media development and manufacturing has announced the expansion of its manufacturing facility in Santa Ana, California to increase overall dry-powder production capacity.

Read More

Health Enterprise East Announce Winners in NHS Innovation Competition 2017
Health Enterprise East (HEE), a healthcare innovation company providing services to the NHS and industry, has announced the winners of its 2017 NHS Innovation Competition.

Read More

Glythera licenses novel payload class from Cancer Research UK for the development of next-generation antibody drug conjugates
Glythera Limited and Cancer Research UK today announced an agreement giving Glythera exclusive, worldwide rights to the charity’s novel CDK11 inhibitor payload series for the development of multiple ADCs conjugated using Glythera’s proprietary PermaLink conjugation platform.

Read More

ADC Bio to invest $11m on Bioconjugation facility
ADC Biotechnology (ADC Bio) has secured investment for the construction of an $11 million* bioconjugation facility at its new site in Deeside, North Wales, UK.

Read More

Product & Industry News
Page 1 to 16 of 64 |     NEXT PAGE >